Kamal V. Gandhi, M.D. – FDA Inspection, Mar 27, 2015

Record Details

This FDA Inspection record concerns Kamal V. Gandhi, M.D., with an inspection on March 27, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Kamal V. Gandhi, M.D.
Inspection Date: March 27, 2015
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · 80d2f022-1b29-46f2-9ebf-e04f9c4a8dd6

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 919812
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kamal V. Gandhi, M.D.

FDA Inspection

Kamal V. Gandhi, M.D.March 27, 2015